Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

POZN:US

6.4500 USD 0.1000 1.53%

As of 20:10:00 ET on 05/29/2015.

Snapshot for POZEN Inc (POZN)

Open: 6.5200 Day's Range: 6.3800 - 6.6000 Volume: 294,273
Previous Close: 6.5500 52wk Range: 5.9600 - 9.7100 1-Yr Rtn: -24.91%

Stock Chart for POZN

No chart data available.
  • POZN:US 6.4500
  • 1D
  • 1M
  • 1Y
6.5500
Interactive POZN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for POZN

Current P/E Ratio (ttm) 7.5369
Estimated P/E(12/2015) 9.6269
Relative P/E vs. SPX 0.4024
Earnings Per Share (USD) (ttm) 0.8558
Est. EPS (USD) (12/2015) 0.6700
Est. PEG Ratio -
Market Cap (M USD) 208.80
Shares Outstanding (M) 32.37
30 Day Average Volume 200,085
Price/Book (mrq) 4.4072
Price/Sale (ttm) 6.9917
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 1.7500
Dividend Ex-Date 12/31/2013
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for POZN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for POZN

POZEN Inc. is a pharmaceutical company that develops therapeutics for diseases with unmet medical needs. The Company's product candidates include migraine treatments as well as is exploring the development of product candidates in other pain-related therapeutic areas.

John R PlachetkaChairman/President/CEOJohn G FortChief Medical Officer
Tomas S BocanegraExec VP:Product DevelopmentDennis L McNamaraSenior VP/Chief Business Ofcr
More Company Profile & Key Executives for POZN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil